Long-term metformin treatment is able to reduce the prevalence of metabolic syndrome and its hepatic involvement in young hyperinsulinaemic overweight patients with polycystic ovarian syndrome

Maria F. Gangale, Luca Miele, Antonio Lanzone, Francesca Sagnella, Daniela Martinez, Anna Tropea, Francesca Moro, Andrea Morciano, Andrea Ciardulli, Carola Palla, Maurizio Pompili, Consuelo Cefalo, Antonio Grieco, Rosanna Apa

Risultato della ricerca: Contributo in rivistaArticolo in rivista

31 Citazioni (Scopus)

Abstract

The objective of this study is to determine the ability of metformin treatment in reducing the prevalence of metabolic syndrome (MS) and its hepatic involvement in young hyperinsulinaemic overweight patients with polycystic ovarian syndrome (PCOS).
Lingua originaleEnglish
pagine (da-a)520-527
Numero di pagine8
RivistaClinical Endocrinology
Volume75
DOI
Stato di pubblicazionePubblicato - 2011

Keywords

  • Adult
  • Female
  • Humans
  • Hyperinsulinism
  • Hypoglycemic Agents
  • Liver
  • Metabolic Syndrome X
  • Metformin
  • Overweight
  • Polycystic Ovary Syndrome
  • Young Adult

Fingerprint

Entra nei temi di ricerca di 'Long-term metformin treatment is able to reduce the prevalence of metabolic syndrome and its hepatic involvement in young hyperinsulinaemic overweight patients with polycystic ovarian syndrome'. Insieme formano una fingerprint unica.

Cita questo